give a miss call on
The 2-year M. Pharmacy program is aimed at creating skilled and competent Pharmaceutical Research Professionals, Technology Analysts, Pre-Clinical & Clinical Scientists, Academicians, Pharma Corporate Executive & Entrepreneur and Clinical Pharmacists. This program trains on all the additional knowledge of medical drugs and aids. The curriculum includes in-depth study of Pharmaceutical Sciences, Discovery Development, Technology, Practice, Industry & Business Development complimented with practical training in high-tech, well-equipped labs in the departments of Pharmaceutical Chemistry, Pharmaceutics, Pharmacology and Pharmacognosy, and in turn help students develop capabilities to become world-class Pharmacists and Scientists
Continuous interaction with industries including Nectar life Sciences, Abbott Healthcare, Unichem, Jubilant Clinsync, Arbro Pharmaceuticals Pvt. Ltd., Dr. Reddy’s Labs, and other organizations for academic, conferences and placements is a special feature during this program. The second-year clinical projects are carried out in hospital in-patient /out-patient settings, either in association with a clinical research organization or a Pharmaceutical company. The College has ‘Memorandum of Association’ in place for the same with:
For this academic year we are offering the following 2-Year Masters Degree programs:
The M. Pharm (Pharmaceutics) program lead to specialization in formulation development, manufacturing technology, and process development areas, which are essential specializations for manufacturing of traditional and novel drug delivery systems. The first year involves theoretical and practical sessions in the following areas: dosage form design; advanced pharmaceutical methods of analysis; drug regulatory affairs; biopharmaceutics and pharmacokinetics; dosage form technology; advances in industrial Pharmacy; and novel drug delivery systems. The second-year projects touch upon formulation development, stability studies, and process validation for traditional and novel drug delivery systems.
Some of the areas which have been taken-up by various batches since 2009, include, Hydrogels, Micro emulsions, Microspheres, Nano spheres, Nano suspensions, Gastroretentive Systems, solid-solid and solid-liquid Dispersed Systems, and development of Modified Excipients.
Continuous interaction with industries including Nectar life Sciences, Abbott Healthcare, Unichem, Jubilant Clinsync, Arbro Pharma, Dr. Reddy’s Labs and other organizations for academic, conferences and placements is a special feature during the course.
This Program leads to specialization in pharmacology, which is an integral part of the drug discovery and drug design processes. These processes deal with the identification of lead molecules that could have potential therapeutic activity due to specific molecular and receptor affinity, and analogous structure to specific sites and proteins in the body. In the first year the Program covers theoretical and practical sessions in the subject’s molecular pharmacology; general pathophysiology; pharmacology and Pharmacotherapeutics I and II; clinical research methodologies; advanced pharmaceutical methods of analysis; drug regulatory affairs; quality assurance and biostatistics; and other subjects. In the second year of the Program students’ take-up several projects that are aimed at developing and exploring novel receptor targets, and mechanisms for drug action in the pathophysiological stages of the disease.
This Program offers a specialization in the clinical drug development methodologies, its regulations, and control. Once the safety and efficacy of a novel chemical entity is established for a drug compound in pre-clinical animal studies, it is put through the process of clinical development. This is where the drug is studied for safety, efficacy and dosing in increasing numbers of human population setting through Phase I–IV clinical trials. The branch offers exposure to subjects on principles of pharmacology and therapeutics; clinical research methodologies; clinical DRUG development; advanced pharmaceutical methods of analysis; drug regulatory affairs; recent advances in pharmacology; quality assurance and biostatistics; and other subjects. The second-year clinical projects are done in hospital inpatient /outpatient settings either in association with a clinical research organization or a pharmaceutical company.
The Master’s program in Drug Regulatory Affairs is a comprehensive specialization in pharmaceutical regulations, which are in practice in different countries to ensure validated procedures for Pharma Research, Technology Transfer for large scale continuous Manufacturing Operations, quality Assurance, Distribution records, recall, Pharmacovigilance. A pharmaceutical product has to be approved for safety, efficacy & procedural compliance & documentation for marketing in US by USFDA, in UK by MHRA, in Europe by EMEA, in Japan by PMDA, in India by CDSCO & similarly for other countries. The course gives details of the structures of these organizational procedures & guidelines to submit documents & dossiers and follow up with these regulatory agencies in the form of DMF, CMC documents, CTD & CTD documents. The professionals with M. Pharm Drug Regulatory Affairs specialization are mandatory & highly paid.
|Per Semester||Rs. 77,000|
The fees for any of the above programs is subject to revision.
*ERP: Only at the time of admission.